Durable remissions with obinutuzumab-based chemoimmunotherapy: long-term follow-up of the phase 1b GALTON trial in CLL

Saved in:
Bibliographic Details
Published in:Blood 2019-02, Vol.133 (9), p.990-992
Main Authors: Brown, Jennifer R., O'Brien, Susan, Kingsley, C. Daniel, Eradat, Herbert, Pagel, John M., Hirata, Jamie, McIver, Tammy, Morariu-Zamfir, Rodica, Kipps, Thomas J.
Format: Article
Language:English
Subjects:
Antibodies, Monoclonal, Humanized
Bendamustine Hydrochloride
Cyclophosphamide
Follow-Up Studies
Humans
Leukemia, Lymphocytic, Chronic, B-Cell
Vidarabine - analogs & derivatives
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2018-06-857714